The analysis of APC, TP53, KRAS, BRAF and PIK3CA mutations indicated that the frequency and pattern of these mutations agree with previously published data on MSS sporadic CRC [30–33] and (http://www-p53.iarc.fr/index.html). This evidence concerns the gene PIK3CA and colorectal carcinoma.